Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Receivables - Net (2016 - 2021)

Historic Receivables - Net for Agios Pharmaceuticals (AGIO) over the last 8 years, with Q4 2021 value amounting to $4.4 million.

  • Agios Pharmaceuticals' Receivables - Net changed N/A to $4.4 million in Q4 2021 from the same period last year, while for Dec 2021 it was $4.4 million, marking a year-over-year change of. This contributed to the annual value of $4.4 million for FY2021, which is 10621.76% up from last year.
  • Per Agios Pharmaceuticals' latest filing, its Receivables - Net stood at $4.4 million for Q4 2021.
  • Agios Pharmaceuticals' Receivables - Net's 5-year high stood at $19.3 million during Q2 2018, with a 5-year trough of $779000.0 in Q2 2017.
  • For the 5-year period, Agios Pharmaceuticals' Receivables - Net averaged around $3.7 million, with its median value being $2.5 million (2019).
  • Per our database at Business Quant, Agios Pharmaceuticals' Receivables - Net skyrocketed by 238087.29% in 2018 and then crashed by 8693.99% in 2019.
  • Quarter analysis of 5 years shows Agios Pharmaceuticals' Receivables - Net stood at $2.4 million in 2017, then rose by 0.57% to $2.5 million in 2018, then tumbled by 37.49% to $1.5 million in 2019, then skyrocketed by 51.66% to $2.3 million in 2020, then soared by 87.57% to $4.4 million in 2021.
  • Its Receivables - Net was $4.4 million in Q4 2021, compared to $2.3 million in Q3 2020 and $2.5 million in Q2 2020.